Join Rob Ririe from Pharosity Consulting as he and representatives from Greenwich Biosciences discuss the challenges and opportunities of...

Pharosity Consulting's Mike McCarthy will be moderating a panel discussion titled "Actively Managing Gross-to-Net to Drive Growth and Value"

As scrutiny mounts on pricing; biosimilars begin to enter the market; companies and portfolios merge; payers become more aggressive with...